Observational study for selection of targeted therapy based on (comprehensive) gene profiling of solid cancer

Observational study for selection of targeted therapy based on (comprehensive) gene profiling of solid cancer - Observational study for selection of targeted therapy based on (comprehensive) gene profiling of solid cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029779

Enrollment

500

Registered

2017-11-07

Start date

2017-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically diagnosed solid tumor (regardless of cytology or tissue biopsy) 2. Written informed consent from patient

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
By using the platform of the next generation sequencing, etc., somatic mutation, copy number alteration, fusion gene etc. in tissue specimens of advanced solid cancer patients are measured. It aims to construct a gene mutation database of oncogene profiles and to examine the clinical significance of clinical sequences that select treatment based on tumor genomic alteration.	—

Countries

Japan

Contacts

Public ContactTakayuki Takahama

Kindai University Faculty of Medicine Department of Medical Oncology

takahama_t@med.kindai.ac.jp072-366-0221

Outcome results